Search
Displaying 1–10 of 33 news results
-
The Foundation in the News
Funds to support advancement of two clinical trials through proof of concept: NPI-001 for retinitis pigmentosa in Usher syndrome and NPI-002 to slow cataract progression.
-
Opus Genetics Appoints Jennifer Hunt Chief Development Officer
The Foundation in the NewsBiopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.
-
Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors
The Foundation in the NewsIndustry Veteran Brings Broad Ophthalmology Research & Development Expertise.
-
RD Fund Announces Series B Financing Behind SalioGen Therapeutics
The Foundation in the NewsInvestment in new portfolio company furthering genetic medicine approaches for individuals affected by retinal degenerative diseases.
-
The Foundation in the News
Series B new investors included Fidelity Management & Research Company LLC, funds and accounts advised by T. Rowe Price Associates, Inc., D1 Capital Partners, SymBiosis, the Cystic Fibrosis Foundation, and the RD Fund (the venture arm of Foundation Fighting Blindness).
-
The Foundation in the News
Dr. Thomas Chalberg has been recognized by the Foundation Fighting Blindness for his pioneering contributions to research and development.
-
Organizations collaborate on inherited macular dystrophy program
The Foundation in the NewsThe Foundation Fighting Blindness and the Nixon Visions Foundation are working together to launch the Nixon Visions Foundation Inherited Macular Dystrophy Program, according to a news release from the organizations.
-
Eyes On Eyecare Raises $1,500 for Foundation Fighting Blindness
The Foundation in the NewsOver 1,400 people participated in charitable giving initiative.
-
The Foundation in the News
Raffaella Toso, PhD, joins as VP Corporate Development & Alliance Management and Florence Paliargues appointed as VP Portfolio Project Management.
-
Opus Genetics Announces Two Key Leadership Appointments
The Foundation in the NewsDr. Ash Jayagopal named Chief Scientific Officer and Mr. Joe Schachle appointed Chief Operating Officer.
.png)
